2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group

Giuseppe Curigliano, Luís Castelo-Branco, Volkmar Müller, Nadia Harbeck

Open source

DOI
10.1016/j.clbc.2026.10.003
Published
2026-11
Container
Clinical Breast Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.clbc.2026.10.003,
  title = {2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group},
  author = {Giuseppe Curigliano and Luís Castelo-Branco and Volkmar Müller and Nadia Harbeck},
  year = {2026},
  journal = {Clinical Breast Cancer},
  doi = {10.1016/j.clbc.2026.10.003},
  url = {https://doi.org/10.1016/j.clbc.2026.10.003}
}

RIS

TY  - JOUR
TI  - 2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group
AU  - Giuseppe Curigliano
AU  - Luís Castelo-Branco
AU  - Volkmar Müller
AU  - Nadia Harbeck
PY  - 2026
JO  - Clinical Breast Cancer
DO  - 10.1016/j.clbc.2026.10.003
UR  - https://doi.org/10.1016/j.clbc.2026.10.003
ER  - 

APA

Curigliano, G., Castelo-Branco, L., Müller, V., & Harbeck, N. (2026). 2026 Key European Guideline Changes for Metastatic Breast Cancer and Their Impact on Practice—Commentary Based on a Virtual Focus Group. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2026.10.003

Source records